Tod Woolf, PhD, Named Executive Director of the Technology Ventures Office at Beth Israel Deaconess Medical Center

Jennifer Kritz (BIDMC Communications) 617-667-7301, jkritz@bidmc.harvard.edu

AUGUST 02, 2019

BOSTON Tod Woolf, PhD, has been named Executive Director of the Technology Ventures Office at Beth Israel Deaconess Medical Center (BIDMC).

In this role, Dr. Woolf will provide leadership and direction for all aspects of BIDMC’s intellectual property management and technology commercialization activities. In addition to supporting faculty in the development of novel technologies, he will also help identify and pursue opportunities for pre-clinical strategic alliances in support of BIDMC’s commitment to research and innovation.  BIDMC, teaching hospital of Harvard Medical School, consistently ranks as a national leader among independent hospitals in National Institutes of Health (NIH) funding.

The mission of BIDMC’s Technology Ventures Office is to promote the public use of BIDMC technologies and innovations by working to create alliances with entrepreneurs, investors and companies to turn BIDMC innovations into products that help change health care.

“We are pleased to welcome Dr. Woolf to BIDMC and to his vital role leading the Technology Ventures Office,” said Gyongyi Szabo, MD, PhD, Chief Academic Officer at BIDMC and Faculty Dean for Academic Programs at Harvard Medical School. “Dr. Woolf’s 25-plus years of leadership experience in biotechnology will be instrumental to fostering collaborations that lead to far-reaching advances in patient care.”

“BIDMC scientists and clinicians perform world-class research, and it is vitally important that we make these discoveries available to patients through collaborations and licensing agreements with industry,” Woolf said. “I am honored to lead BIDMC’s Technology Ventures Office team as we work to advance BIDMC’s innovations from the laboratory to patient care.”

Dr. Woolf brings to BIDMC more than 25 years of leadership experience at biotechnology companies. He most recently served as a Technology Licensing Officer at the Massachusetts Institute of Technology in Cambridge, MA. Dr. Woolf earned a Bachelor of Science in Cellular and Molecular Biology from the University of Michigan, and a Doctorate in Biology at Harvard University, working in Professor Doug Melton’s laboratory.

About Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding.

BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Healthcare, Beth Israel Deaconess HealthCare, Community Care Alliance and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Rehabilitation Center and is a research partner of Dana-Farber/Harvard Cancer Center and the Jackson Laboratory. BIDMC is the official hospital of the Boston Red Sox. For more information, visit www.bidmc.org.

BIDMC is part of Beth Israel Lahey Health, a new health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,000 physicians and 35,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.